These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3882856)

  • 61. Immune responses to the capsular polysaccharide of Mycoplasma dispar in calves and mice.
    Bansal P; Adegboye DS; Rosenbusch RF
    Comp Immunol Microbiol Infect Dis; 1995 Sep; 18(4):259-68. PubMed ID: 8549115
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.
    Cryz SJ; Fürer E; Cross AS; Wegmann A; Germanier R; Sadoff JC
    J Clin Invest; 1987 Jul; 80(1):51-6. PubMed ID: 3110215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quantitative determination in human sera of vaccine-induced antibody to type-specific polysaccharides of group B streptococci using an enzyme-linked immunosorbent assay.
    Eisenstein TK; De Cueninck BJ; Resavy D; Shockman GD; Carey RB; Swenson RM
    J Infect Dis; 1983 May; 147(5):847-56. PubMed ID: 6341484
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Humoral immunity against capsule polysaccharide protects the host from magA+ Klebsiella pneumoniae-induced lethal disease by evading Toll-like receptor 4 signaling.
    Wu MF; Yang CY; Lin TL; Wang JT; Yang FL; Wu SH; Hu BS; Chou TY; Tsai MD; Lin CH; Hsieh SL
    Infect Immun; 2009 Feb; 77(2):615-21. PubMed ID: 19015249
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
    Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
    J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide.
    Musher DM; Luchi MJ; Watson DA; Hamilton R; Baughn RE
    J Infect Dis; 1990 Apr; 161(4):728-35. PubMed ID: 2319166
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of capsular polysaccharide of Klebsiella pneumoniae on host resistance to bacterial infections. III. Further study of its effects on interactions between peritoneal leukocytes and virulent Salmonella enteritidis.
    Kato N; Kato O; Nakashima I; Naito S; Asai J
    Microbiol Immunol; 1979; 23(5):369-82. PubMed ID: 388155
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.
    Bruge J; Bouveret-Le Cam N; Danve B; Rougon G; Schulz D
    Vaccine; 2004 Mar; 22(9-10):1087-96. PubMed ID: 15003635
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vaccination against 77 capsular types of Klebsiella aerogenes with polyvalent Klebsiella vaccines.
    Jones RJ; Roe EA
    J Med Microbiol; 1984 Dec; 18(3):413-21. PubMed ID: 6389878
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations.
    Fournier JM; Jolivet-Reynaud C; Riottot MM; Jouin H
    Infect Immun; 1981 May; 32(2):420-6. PubMed ID: 7019071
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A vaccine in humans.
    Cryz SJ; Sadoff JC; Cross AS; Fürer E
    Antibiot Chemother (1971); 1989; 42():177-83. PubMed ID: 2512836
    [No Abstract]   [Full Text] [Related]  

  • 72. [Protective activity of a cell-free Klebsiella vaccine in relation to different Klebsiella pneumoniae serovars].
    Kurbatova EA; Egorova NB; Kiseleva BS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):80-3. PubMed ID: 6385585
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effect of a hydroxylamine Klebsiella vaccine on the rate of elimination of the causative agent and on indices of humoral immunity].
    Kurbatova EA; Lazareva ES; Gladus MA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):75-9. PubMed ID: 3061265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enzyme-linked immunospecific antibody test for detecting antibody to Klebsiella.
    Rissing JP; Buxton TB; Moore WL; Ozawa T; Moore WL
    J Clin Microbiol; 1978 Dec; 8(6):704-7. PubMed ID: 370145
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.
    Riottot M; Fournier JM; Pillot J
    Infect Immun; 1979 May; 24(2):476-82. PubMed ID: 378855
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of capsular polysaccharide of Klebsiella pneumoniae on host resistance to bacterial infections. I. Induction of increased susceptibility to infections in mice.
    Kato N; Kato O; Nakashima I
    Jpn J Microbiol; 1976 Jun; 20(3):163-72. PubMed ID: 9528
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interferon production in mice by the capsular polysaccharide of Klebsiella pneumoniae.
    Kato N; Nakashima I; Ota M
    Infect Immun; 1975 Jul; 12(1):1-6. PubMed ID: 166921
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunological cross-reactivity between Enterobacter aerogenes and Klebsiella capsular polysaccharides.
    Cryz SJ; Pitt TL; Ayling-Smith B; Que JU
    Microb Pathog; 1990 Aug; 9(2):127-30. PubMed ID: 2277587
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Role of capsular polysaccharide and lipopolysaccharide of Klebsiella pneumoniae in experimental mice pneumonia model].
    Tateda K; Goto S; Hirakata Y; Yamaguchi K; Matsumoto T; Furuya N; Shimoguchi K; Irifune K; Kaku M; Kohno S
    Kansenshogaku Zasshi; 1992 Aug; 66(8):1053-61. PubMed ID: 1402109
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Passive protective activities of normal human sera against infection with strain K-9 of Klebsiella pneumoniae].
    Takahashi M; Ichiman Y; Ohshima Y; Yoshida K
    Kansenshogaku Zasshi; 1984 Nov; 58(11):1194-8. PubMed ID: 6442331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.